David Powers

1.4k total citations
26 papers, 697 citations indexed

About

David Powers is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, David Powers has authored 26 papers receiving a total of 697 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in David Powers's work include Glycosylation and Glycoproteins Research (3 papers), Disability Education and Employment (3 papers) and Melanoma and MAPK Pathways (3 papers). David Powers is often cited by papers focused on Glycosylation and Glycoproteins Research (3 papers), Disability Education and Employment (3 papers) and Melanoma and MAPK Pathways (3 papers). David Powers collaborates with scholars based in United States. David Powers's co-authors include Nuria Tamayo, Celia Dominguez, Jeffrey M. Stadel, D. Berry, A. Nichols, James M. Samanen, Raul R. Calvo, Todd T. Romoff, Mark W. Strohsacker and Barbara L. Storer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Medicinal Chemistry.

In The Last Decade

David Powers

25 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Powers United States 13 410 128 120 86 67 26 697
Fabio Gasparri Italy 16 479 1.2× 74 0.6× 183 1.5× 61 0.7× 45 0.7× 37 896
G.B. Stauber United States 10 689 1.7× 177 1.4× 45 0.4× 42 0.5× 81 1.2× 13 826
Laurie Witucki United States 9 760 1.9× 166 1.3× 140 1.2× 17 0.2× 56 0.8× 12 1.0k
Anand Mayasundari United States 14 434 1.1× 91 0.7× 68 0.6× 36 0.4× 23 0.3× 22 597
Sonia Troiani Italy 11 631 1.5× 44 0.3× 246 2.0× 39 0.5× 45 0.7× 12 845
Karen Affleck United Kingdom 17 489 1.2× 136 1.1× 567 4.7× 54 0.6× 113 1.7× 24 1.2k
Jacky Chi Ki Ngo Hong Kong 19 893 2.2× 64 0.5× 81 0.7× 36 0.4× 40 0.6× 45 1.2k
Henry E. Pelish United States 10 594 1.4× 128 1.0× 130 1.1× 26 0.3× 84 1.3× 22 913
Douglas A. Austen United States 9 613 1.5× 42 0.3× 176 1.5× 52 0.6× 69 1.0× 12 861
Megan Chircop Australia 17 723 1.8× 64 0.5× 100 0.8× 54 0.6× 101 1.5× 26 1.2k

Countries citing papers authored by David Powers

Since Specialization
Citations

This map shows the geographic impact of David Powers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Powers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Powers more than expected).

Fields of papers citing papers by David Powers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Powers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Powers. The network helps show where David Powers may publish in the future.

Co-authorship network of co-authors of David Powers

This figure shows the co-authorship network connecting the top 25 collaborators of David Powers. A scholar is included among the top collaborators of David Powers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Powers. David Powers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Archibeque, Ivonne, et al.. (2014). Characterization of Bispecific T-cell Engager (BiTE®) Antibodies with a High-Capacity T-cell Dependent Cellular Cytotoxicity (TDCC) Assay. SLAS DISCOVERY. 20(4). 519–527. 18 indexed citations
2.
Xu, Stanley, Susan Shetterly, David Powers, et al.. (2011). Extension of Kaplan-Meier Methods in Observational Studies with Time-Varying Treatment. Value in Health. 15(1). 167–174. 28 indexed citations
3.
Han, Chun-Ya, Youping Wang, David Powers, et al.. (2009). Small molecules with potent osteogenic-inducing activity in osteoblast cells. Bioorganic & Medicinal Chemistry Letters. 19(5). 1442–1445. 25 indexed citations
4.
Kaller, Matthew R., Wenge Zhong, Charles M. Henley, et al.. (2009). Design and synthesis of 6-oxo-1,6-dihydropyridines as CDK5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(23). 6591–6594. 8 indexed citations
5.
Rzasa, Robert M., Matthew R. Kaller, Gang Liu, et al.. (2007). Structure–activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors. Bioorganic & Medicinal Chemistry. 15(20). 6574–6595. 30 indexed citations
6.
Zhong, Wenge, Hu Liu, Matthew R. Kaller, et al.. (2007). Design and synthesis of quinolin-2(1H)-one derivatives as potent CDK5 inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(19). 5384–5389. 23 indexed citations
7.
Ross, Sandra L., Teresa C. Chen, Violeta Yu, et al.. (2006). High-Content Screening Analysis of the p38 Pathway: Profiling of Structurally Related p38 α Kinase Inhibitors Using Cell-Based Assays. Assay and Drug Development Technologies. 4(4). 397–409. 15 indexed citations
8.
Tamayo, Nuria, David Powers, Yanyan Tudor, et al.. (2005). Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters. 15(9). 2409–2413. 40 indexed citations
9.
Dominguez, Celia, David Powers, & Nuria Tamayo. (2005). p38 MAP kinase inhibitors: many are made, but few are chosen.. PubMed. 8(4). 421–30. 138 indexed citations
10.
Wong, Angela, Shing Mei Hwang, Kyung Johanson, et al.. (1998). Binding of [3H]-SK&F 107260 and [3H]-SB 214857 to Purified Integrin αIIbβ3: Evidence for a Common Binding Site for Cyclic Arginyl-Glycinyl-Aspartic Acid Peptides and Nonpeptides. Journal of Pharmacology and Experimental Therapeutics. 285(1). 228–235. 3 indexed citations
11.
Stadel, Jeffrey M., David J. Ecker, David Powers, et al.. (1994). Characterization of Mamalian G S -α Proteins Expressed in Yeast. Journal of Receptor Research. 14(6-8). 357–379. 2 indexed citations
12.
Samanen, James M., Todd T. Romoff, Raul R. Calvo, et al.. (1991). Development of a small RGD peptide fibrinogen receptor antagonist with potent antiaggregatory activity in vitro. Journal of Medicinal Chemistry. 34(10). 3114–3125. 156 indexed citations
13.
Powers, David & Patricia J. Anderson. (1991). Advocacy for Latchkey Children: A New Challenge for Special Educators. Teaching Exceptional Children. 23(3). 49–51. 1 indexed citations
14.
Nichols, A., Paul F. Koster, Jean A. Smith, et al.. (1990). SK&F 106760, a novel GPIIB/IIIA antagonist: antithrombotic activity and potentiation of streptokinase-mediated thrombolysis. European Journal of Pharmacology. 183(5). 2019–2019. 12 indexed citations
15.
Ecker, David J., Jeffrey M. Stadel, Tauseef R. Butt, et al.. (1989). Increasing gene expression in yeast by fusion to ubiquitin. Journal of Biological Chemistry. 264(13). 7715–7719. 86 indexed citations
16.
Powers, David. (1983). Mainstreaming and the Inservice Education of Teachers. Exceptional Children. 49(5). 432–439. 12 indexed citations
17.
Powers, David, et al.. (1980). Interaction Research: An Approach to the Investigation of College Teaching Methods.. Educational Technology archive. 20(8). 11–18. 4 indexed citations
18.
Powers, David. (1979). Mainstreaming EMR Pupils at the Secondary Level: A Consideration of the Issues.. ˜The œHigh School journal. 63(3). 1 indexed citations
19.
Baldwin, Thomas, Mathias Ziegler, & David Powers. (1979). Covalent structure of subunits of bacterial luciferase: NH2-terminal sequence demonstrates subunit homology.. Proceedings of the National Academy of Sciences. 76(10). 4887–4889. 37 indexed citations
20.
Powers, David, et al.. (1976). A concurrent validity study of the KeyMath Diagnostic Arithmetic Test.. PubMed. 14(6). 48–48. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fabio Gasparri Breakdown of academic impact, for papers by G.B. Stauber Breakdown of academic impact, for papers by Laurie Witucki Breakdown of academic impact, for papers by Anand Mayasundari Breakdown of academic impact, for papers by Sonia Troiani Breakdown of academic impact, for papers by Karen Affleck Breakdown of academic impact, for papers by Jacky Chi Ki Ngo Breakdown of academic impact, for papers by Henry E. Pelish Breakdown of academic impact, for papers by Douglas A. Austen Breakdown of academic impact, for papers by Megan Chircop
Rankless by CCL
2026